Thom Tillis actually said...
I will say, for the Johnson & Johnson product, I am very curious to see how that product will be discussed at FDA's Advisory Committee on Friday.
Context
Tillis expresses interest in the FDA's discussion on the Johnson & Johnson vaccine.
02/23/2021